Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV5080 in Uncomplicated Influenza
NCT05093998Phase 3Unknown
- Sponsor
- Viriom Inc
- Start
- Jan 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of AV5080 in influenza, sponsored by Viriom Inc. Status: unknown.
02
Drugs
AV5080
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05093998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05093998.